跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AT-1000
首页
药物
AT-1000
AT-1000
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF ATOPIC DERMATITIS CONTAINING IL-31 ANTAGONIST AS ACTIVE INGREDIENT
申请人: CHUGAI PHARMACEUTICAL CO LTD
优先权: 2015
CN
EP
US
WO
11 件公开
Pet food composition
申请人: HILLS PET NUTRITION INC
优先权: 2022
CN
Apricot forest tea meal, mountain kudzuvine root and lotus seed meal for assisting in reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof
申请人: CHANGSHA XINGLIN CUKANG HEALTH CO LTD
优先权: 2025
CN
Cosmetic packaging and application unit for thixotropic compositions
申请人: OREAL
优先权: 2009
EP
VIRAL VECTOR COMPOSITIONS AND METHODS OF USE THEREOF
申请人: LOGICBIO THERAPEUTICS INC
优先权: 2021
CN
US
2 件公开
Imatinib for use in the treatment of stroke
申请人: HAMRA INVEST AB
优先权: 2016
CN
US
3 件公开
SURFACE TREATING CONDITIONING COMPOSITION
申请人: PROCTER & GAMBLE
优先权: 2015
CN
COMPOSITIONS COMPRISING DRAGLINE SPIDER SILK
申请人: SEEVIX MAT SCIENCES LTD
优先权: 2026
US
药物
反馈